{"id":"https://genegraph.clinicalgenome.org/r/70fe0086-3ac7-446b-808b-3087d9c30a00v1.0","type":"EvidenceStrengthAssertion","dc:description":"There is abundant evidence published associating the FANCA gene with Fanconi anemia complementation group A, since the gene-disease relationship was first proposed by Fanconi Anaemia/Breast Cancer Consortium (1996). Multiple case level studies have been performed with FA patients that have variants in the FANCA gene. Eight of the FA proteins (FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL, and FANCM) are part of a nuclear multiprotein core complex which triggers activating monoubiquitination of the FANCD2 in the FA/BRCA DNA repair pathway. Multiple Fanca deficient mouse models have been established to show consistent phenotypes with FA patients including growth retardation, microphthalmia, craniofacial malformations, and hypogonadism. All of these types of evidence are consistent with a definitive relationship between the FANCA gene and Fanconi anemia complementation group A.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/70fe0086-3ac7-446b-808b-3087d9c30a00","GCISnapshot":"https://genegraph.clinicalgenome.org/r/ceecf6ee-6700-40e5-a0d3-f7891805daac","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/ceecf6ee-6700-40e5-a0d3-f7891805daac_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2020-09-01T00:00:00Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/ceecf6ee-6700-40e5-a0d3-f7891805daac_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2019-04-19T16:00:00.000Z","role":"Approver"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ceecf6ee-6700-40e5-a0d3-f7891805daac_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ceecf6ee-6700-40e5-a0d3-f7891805daac_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7a770db6-86fc-44c6-bd4d-17334eba855b","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1a3de60e-e1d3-4915-86ca-9f3cc1e70cc3","type":"Finding","dc:description":"The hematological parameters in Fanca deficient mice showed a slightly decreased platelet count and a slightly increased erythrocyte mean cell volume in mice at young age, but this did not progress to anemia. Consistent with the clinical phenotype of FA patients, both male and female mice showed hypogonadism and impaired fertility. Furthermore, embryonic fibroblasts of the knock-out mice exhibited spontaneous chromosomal instability and were hyper-responsive to the clastogenic effect of the crosslinker mitomycin C.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10915769","rdfs:label":"Mice with a targeted disruption of the FA homolog Fanca","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/24b31972-d3da-423a-8c85-4373a51139ab","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1b49b434-a626-4fd1-a377-84ab5f28eb78","type":"Finding","dc:description":"Fanca tm1.1Hsc homozygotes displayed FA-like phenotypes including growth retardation, microphthalmia, craniofacial malformations, and hypogonadism.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12913077","rdfs:label":"Targeted disruption of Fanca displayed FA-like phenotypes","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/ceecf6ee-6700-40e5-a0d3-f7891805daac_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f62f30b3-51e2-4099-8932-112ed53b554f","type":"EvidenceLine","dc:description":"Eight FA proteins (FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL, and FANCM)","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c1e8e959-465b-47cc-9822-9d80ebca7efa","type":"Finding","dc:description":"Eight of the FA proteins (FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL, and FANCM) are part of a nuclear multiprotein core complex which triggers activating monoubiquitination of the FANCD2 protein during S phase of the growth cycle and after exposure to DNA crosslinking agents. The FA/BRCA pathway is involved in the repair of DNA damage. They all cause Fanconi anaemia.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29376519","rdfs:label":"Eight of the FA proteins are assembled in a nuclear complex","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/ceecf6ee-6700-40e5-a0d3-f7891805daac_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1776bed7-4d64-4ef6-bc28-553fdfcaed18_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A deletion in the FANCA gene of 156 bp (from nucleotides 1515 to 1670) that spans 2 exons. This 156-bp deletion did not result in a frameshift but led to the deletion of 52 amino acids from the protein.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dab00962-3dd3-4879-aef9-a3b60e22c373","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8896564","rdfs:label":"IFAR345/2","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"Fanconi anemia","phenotypes":"obo:HP_0005528","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"SSCP","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/1776bed7-4d64-4ef6-bc28-553fdfcaed18_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8896564","allele":{"id":"https://genegraph.clinicalgenome.org/r/315ffde8-da69-42cd-8c63-2f501fce84e3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"FANCA, 156-BP DEL, NT1515","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/3441"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/0276f616-3099-4427-a0e9-2d146d5bc3bf_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Homozygous deletion of a G at nucleotide 1615 in exon 17 of the FANCA gene.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c98c6224-d015-4609-8f03-ac13164d2a85","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10431244","rdfs:label":"EUFA704","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"PCR","phenotypeFreeText":"Fanconi anemia","phenotypes":"obo:HP_0005528","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"SSCP","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/0276f616-3099-4427-a0e9-2d146d5bc3bf_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10431244","allele":{"id":"https://genegraph.clinicalgenome.org/r/ad11be2c-d5bc-4714-b557-e9514da58da8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000135.2(FANCA):c.1615delG (p.Asp539Thrfs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/3443"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/1dd7cc8f-8c76-47c0-b64f-701ee34e9cd2_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Two star variant in ClinVar. A deletion of 1 of 2 direct repeats of the sequence TTGG at nucleotides 1155-1162 of the FANCA gene. The deletion resulted in a frameshift and the production of a termination codon 42 residues downstream.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2bcaa61d-4ce3-4ee9-8492-4020fc168053","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8896564","rdfs:label":"EUFA444","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"Fanconi anemia","phenotypes":"obo:HP_0005528","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"SSCP","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/1dd7cc8f-8c76-47c0-b64f-701ee34e9cd2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8896564","allele":{"id":"https://genegraph.clinicalgenome.org/r/5f0ede74-c8e4-4e8c-a046-4b6df3a08721","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000135.2(FANCA):c.1115_1118delTTGG (p.Val372Alafs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/3440"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/7c8ee5de-acef-4d1b-b44e-b9d92c4e26c7_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Compound heterozygous for 2 mutations in the FANCA gene: a 113-bp deletion spanning nucleotides 938 to 1050, and a 156-bp deletion. The 113-bp deletion removes a single exon from the coding sequence and creates a premature stop codon 2 residues downstream.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/60a72f3c-ab8d-41f6-9d4d-cd7e04ddeb73","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8896564","rdfs:label":"IFAR270/2","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"Fanconi anemia","phenotypes":"obo:HP_0005528","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"SSCP","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/7c8ee5de-acef-4d1b-b44e-b9d92c4e26c7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8896564","allele":[{"id":"https://genegraph.clinicalgenome.org/r/315ffde8-da69-42cd-8c63-2f501fce84e3"},{"id":"https://genegraph.clinicalgenome.org/r/c2ef43ce-c58d-4355-a54c-f6f093a907b9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000135.2(FANCA):c.894_1006del113 (p.Trp298Cysfs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/3442"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ceecf6ee-6700-40e5-a0d3-f7891805daac_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ff8c6ce0-e74a-4fa7-9561-aaeaa32ee58b_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8896564","rdfs:label":"EUFA444 and EUFA445","family":{"id":"https://genegraph.clinicalgenome.org/r/ff8c6ce0-e74a-4fa7-9561-aaeaa32ee58b","type":"Family","rdfs:label":"EUFA444 and EUFA445","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/2bcaa61d-4ce3-4ee9-8492-4020fc168053"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Fanconi anemia","phenotypePositiveAllelePositive":2,"phenotypes":"obo:HP_0005528","proband":{"id":"https://genegraph.clinicalgenome.org/r/2bcaa61d-4ce3-4ee9-8492-4020fc168053"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/5d971336-e95a-4fe1-9392-9d5da400f1f3_proband_score_evidence_line","type":"EvidenceLine","dc:description":"An intragenic deletion of exons 12-31 of the FANCA gene as accounting for 60% of Fanconi anemia chromosomes in 46 unrelated Afrikaner FA patients. It is a founder variant.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/303c8abe-e229-4c53-a214-4c215e88ed95","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11344308","rdfs:label":"46 unrelated Afrikaner FA patients","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"Fanconi anemia","phenotypes":"obo:HP_0005528","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/5d971336-e95a-4fe1-9392-9d5da400f1f3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11344308","allele":{"id":"https://genegraph.clinicalgenome.org/r/92001c1e-1e75-457b-88f9-521dfd481454","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000135.2(FANCA):c.1007_3066del","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/3445"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/23ab4318-f2e1-4ef0-aecc-6ac25be44a49_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A 274-bp deletion of the FANCA gene in an Italian patient with Fanconi anemia, which resulted in the loss of nucleotides 1671 to 1944, a frameshift, and the creation of a premature termination codon 6 residues downstream.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/88219d27-7ff9-4a5b-b752-9582a4e8adc3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8896564","rdfs:label":"VU337","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"Fanconi anemia","phenotypes":"obo:HP_0005528","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"SSCP","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/23ab4318-f2e1-4ef0-aecc-6ac25be44a49_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8896564","allele":{"id":"https://genegraph.clinicalgenome.org/r/5112d140-d1c8-4836-bc92-8fdd1209f4bb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000135.2:c.1627_1900del274","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/3439"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/4e342ea4-1dd5-49c0-888d-3907f91ab907_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Two star variant in ClinVar. A 3559insG frameshift in exon 36 of the FANCA gene on both alleles.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/04c3d4b1-e912-4211-9c45-7d6f3122dde4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10431244","rdfs:label":"EUFA393","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"PCR","phenotypeFreeText":"Fanconi anemia","phenotypes":"obo:HP_0005528","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"SSCP","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/4e342ea4-1dd5-49c0-888d-3907f91ab907_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10431244","allele":{"id":"https://genegraph.clinicalgenome.org/r/8155822a-cd38-4d1d-88a2-b6c1894f4818","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000135.3(FANCA):c.3558dup (p.Arg1187Glufs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/3444"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":580,"specifiedBy":"GeneValidityCriteria6","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/5pxu-dkuFhk","type":"GeneValidityProposition","disease":"obo:MONDO_0009215","gene":"hgnc:3582","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_ceecf6ee-6700-40e5-a0d3-f7891805daac-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}